Overview

Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Treatments

Status:
Not yet recruiting

Trial end date:
2027-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the superiority of esmolol echocardiography over conventional echocardiography in the diagnosis of subclinical myocardial involvement associated with diabetes mellitus 2, cirrhosis and antineoplastic treatments.

Phase:

Phase 3

Details

Lead Sponsor:

Consorcio Centro de Investigación Biomédica en Red (CIBER)

Collaborator:

Instituto de Salud Carlos III

Treatments:

Esmolol